Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* pregnant or lactating women * hypersensitivity to tocilizumab * patients or authorized family member unwilling to sign informed consent to participate in this study * uncontrolled tuberculosis, or any uncontrolled fungal infection (eg: candidemia)	* pregnant or lactating women * hypersensitivity to tocilizumab * patients or authorized family member unwilling to sign informed consent to participate in this study * uncontrolled tuberculosis, or any uncontrolled fungal infection (eg: candidemia)
Oct. 26, 2020, 11:31 p.m.	usa	- pregnant or lactating women - hypersensitivity to tocilizumab - patients or authorized family member unwilling to sign informed consent to participate in this study - uncontrolled tuberculosis, or any uncontrolled fungal infection (eg: candidemia)	- pregnant or lactating women - hypersensitivity to tocilizumab - patients or authorized family member unwilling to sign informed consent to participate in this study - uncontrolled tuberculosis, or any uncontrolled fungal infection (eg: candidemia)